Telomere Science still has a lot of work ahead of itself…there are many factors that contribute to the aging process…so if a test can predict when I will die…perhaps in the future we can manipulate the strands of our DNA to extend our lives to 120 years of age. It sounds like science fiction ….but remember many ideas have started out as an impossibility…only to develop into a feasible application to enhance the quality of life.
http://www.yepod.com/?p=14786
Pass it on,
Dr Anthony
This article titled “Can a blood test really tell you when you’ll die?” was written by Giles Tremlett, for The Guardian on Tuesday 11th October 2011 19.00 UTC
As a taxi takes me across Madrid to the laboratories of Spain’s National Cancer Research Centre, I am fretting about the future. I am one of the first people in the world to provide a blood sample for a new test, which has been variously described as a predictor of how long I will live, a waste of time or a handy indicator of how well (or badly) my body is ageing. Today I get the results.
Some newspapers, to the dismay of the scientists involved, have gleefully announced that the test – which measures the telomeres (the protective caps) on the ends of my chromosomes – can predict when I will die. Am I about to find out that, at least statistically, my days are numbered? And, if so, might new telomere research suggesting we can turn back the hands of the body’s clock and make ourselves “biologically younger” come to my rescue?
The test is based on the idea that biological ageing grinds at your telomeres. And, although time ticks by uniformly, our bodies age at different rates. Genes, environment and our own personal habits all play a part in that process. A peek at your telomeres is an indicator of how you are doing. Essentially, they tell you whether you have become biologically younger or older than other people born at around the same time.
The key measure, explains María Blasco, a 45-year-old molecular biologist, head of Spain’s cancer research centre and one of the world’s leading telomere researchers, is the number of short telomeres. Blasco, who is also one of the co-founders of the Life Length company which is offering the tests, says that short telomeres do not just provide evidence of ageing. They also cause it. Often compared to the plastic caps on a shoelace, there is a critical level at which the fraying becomes irreversible and triggers cell death. “Short telomeres are causal of disease because when they are below a [certain] length they are damaging for the cells. The stem cells of our tissues do not regenerate and then we have ageing of the tissues,” she explains. That, in a cellular nutshell, is how ageing works. Eventually, so many of our telomeres are short that some key part of our body may stop working.
The research is still in its early days but extreme stress, for example, has been linked to telomere shortening. I think back to a recent working day that took in three countries, three news stories, two international flights, a public lecture and very little sleep. Reasonable behaviour, perhaps, for someone in their 30s – but I am closer to my 50s. Do days like that shorten my expected, or real, life-span?
People with similar worries – or, perhaps, just Woody Allen-style neuroses about their health – have begun to contact the company set up by Blasco. Requests have poured in from around the world since a headline writer at the Independent, perhaps misled by Life Length‘s ambiguous name, invited readers to find out about “The £400 test that tells you how long you’ll live.” The internet did the rest.
Originally set up to help researchers and the pharmaceutical, health food and cosmetics industries test the impact of their products on telomeres, the flood of individual requests has caught Blasco’s still tiny company by surprise. But the test is available, as of this month, via doctors in Spain and Portugal and there are plans to make it easier to carry out in the UK and the US as soon as possible. It sees a potential gold-mine in testing of what it calls people’s “biological age” – though it is by no means alone in the field. So what can Blasco tell me about my test?
“You actually have very good news,” she says, pointing at a chart that looks as if it has been blasted by shotgun pellets. My telomeres – especially the more dangerous, shortest ones – are in better shape than would be normal for my age. The pellet points are individual results from those people who have been tested and introduced into this database so far, and the red dot representing my blood sample is on the better side of the two graphs Blasco shows me. One graph shows median telomere length, while the other shows how many crucially short telomere endings I have. In each case, a line on the graph shows the average result against age. The test on some 100,000 of my telomeres, compared with the other results on the admittedly small database being used by Life Length when this test was done in the summer, give me a “biological age” six years below my real age. With only 90 other men on the chart so far, all with different lifestyles and genetic backgrounds to mine, I should avoid feeling smug. Eventually, when there are thousands or more on the database, I might get a better idea of what results people more like me should expect. I have a reasonably healthy lifestyle, after all, and previous generations on both sides of my family have been long-lived.
However, according to a New York Times interview with 2009 Nobel prize-winner Carol Greider – who Blasco trained under – individual telomere tests are not much use. “The science really isn’t there to tell us what the consequences are of your telomere length,” she said.
Blasco, obviously, disagrees. So does Elizabeth Blackburn, who shared the Nobel prize for telomere research with Greider and Jack Szostak, and has set up her own Telome Health company to start offering tests later this year.
Blasco compares the current state of telomere testing to the early days of cholesterol tests – and believes it should become common once the price drops and research is done to beef up databases, improve interpretation and create telomere-restoring treatments. “This is a different kind of marker. It is a new, molecular marker. Even though we measure telomere length in blood cells, it has been shown to be an indicator of the degree of telomere shortening in the whole organism,” she says. “And we think it is very powerful, based on what we know from hard science.” Even so, she is insistent that the test is not a magic measure of individual life length. “We don’t tell anyone how long they will live.
“It is the doctor – and we want to do this with doctors – who will tell you what is known about the meaning of this measurement and what you can do and what you cannot do,” says Blasco. In fact, the benefits of telomere science still lie mostly in the future. As with early cholesterol tests, a doctor is currently unable to tell you much about what those results mean – or what you can do about a bad result, beyond fairly obvious advice about looking after your health.
I notice that a few of the 90 men on my chart have apparently alarming results. Their telomeres indicate a “biological age” 20 years or more higher than their real age. This means that, at least statistically, they may be much closer to death than most people their age. One of these men comes from a family with a long history of early cancers, according to Life Length’s CEO Stephen Matlin. He has offered those with worryingly high results a free second test after three months, to see whether anything has changed. My report also warns, however, that results may reflect temporary illness or ongoing medical treatments – effectively skewing them. And some results on the chart look plain bizarre. One tester, for example, appears to have – at least statistically – a biological age of around 120. Two people aged above 60, together with a clutch of 30-year-olds, have an estimated biological age below zero – presumably because their telomeres are in better shape than might be expected of the average baby. Life Length said this reflected the fact that little research had been done on the telomeres of the very young.
Individual testing, then, is still in nappies. Far more exciting are the possible future advances to come from telomere research, says Blasco. “One is telomerase activation, because of its potential to reverse ageing. And proving which diseases can benefit from telomerase activation, in order for this to be something druggable.”
“Some of the new [research] papers appearing in top journals are to do with telomorase activation,” she says. “That is one aspect. The other is that we are seeing a lot of epidemiological studies showing correlations between telomere length and certain diseases, and which habits are good or bad for telomere length.”
She says the idea that telomeres can be “re-elongated” and, hence, that biological age can be reversed does not open the door to immortality – even if scientists have been able to extend a mouse’s age by up to 40%. “That’s a lot, but nobody has been able to make a mouse that is immortal,” she says.
It does, however, throw up philosophical and ethical dilemmas. The US Food and Drug Administration (FDA), for example, refuses to approve drugs that are simply designed to prevent ageing. “Although I – and many more scientists – believe ageing is the cause of diseases, this is not perceived like that yet by the FDA,” says Blasco. “But what is clear is that there are a number of diseases associated with ageing which are caused because our cells age.”
Activating telomerase to counter that, she says, might help prevent major illnesses and allow drugs to be approved by the FDA. If drugs are found to activate telomerase and prevent, say, Parkinson’s disease, Alzheimer’s disease or some cardiovascular problems then the inevitable result will be not just a healthier life, but also a longer one.
Blackburn agrees that the idea that the new tests can tell you your life length is silly, but she insists that the evidence connecting telomere length and disease risk is becoming clearer.
“We and other groups are seeing clear statistical links between telomere shortness and risk for a variety of diseases that are becoming very common, such as cardiovascular disease, diabetes and certain cancers,” she told the nature.com website in August. “We have also looked at chronic psychological stress, including depression and post-traumatic stress disorder, and more and more we see associations with telomere shortness. There are even links with education — in one study telomere shortness was related to not finishing school. We’re seeing the data unfolding in front of us. A lot of them are not published yet.”
So what has telomere testing done for me? Not a lot, frankly, though I might have reacted differently had I been dangerously off the chart. Nor am I a woman in her 30s, who might like to know how fast the biological clock that may eventually limit fertility is ticking.
I am tempted to repeat the test again, mainly out of a competitive desire to get better, but only if (as on this occasion, when Life Length waived the $500 fee) I can get it for free. Far more interesting, however, has been the glimpse of the future – when telomere testing, and popping pills to repair the tips of our chromosomes, may allow us to live both longer and healthier. I am persuaded, too, that the aim should be to make sure we live our years out in good health. So why all the rushing about? Time, perhaps, to take things more calmly.
guardian.co.uk © Guardian News & Media Limited 2010
Published via the Guardian News Feed plugin for WordPress.
Why I’m off for some vitamin D – until the sun comes out
There’s has always been discussion on the pros and cons of vitamin supplementation in our diets. I see no harm in taking vitamin D and other supplements as long one stays within the normal dosage recommedated by physicians and FDA guidelines. Usually common sense dictates following the instructions listed on the bottle or physician’s orders. Never decide to begin ingesting supplements until your have discussed doing so with your family doctor first. Vitamin D is an important vitamin from strong bones,growth, and for many chemical reactions that occur within our bodies. Moderation is the key to absorbing sufficient Vitamin D. As for sunshine….be careful not be burn ..wear sunscreen protection…
http://www.yepod.com/?p=31666
That’s my comment…pass it on…
Dr Anthony
Vitamin D is in the news again, and while the experts squabble over it, I’m off to buy myself some supplements. The chief medical officer for England has told GPs like me to advise those at risk to take supplements. And since half the adult population of the UK is lacking vitamin D in the winter months and deficiency is being linked to a growing list of health problems, I can’t see a good reason not to take a small multivitamin a day – at least until the sun comes out. I’ll stick to the recommended daily amount as you can have too much of a good thing, even vitamins.
Vitamin D is essential for bone growth and health, and deficiency can cause rickets in the young and a condition called chondromalacia in adults. You wouldn’t think rickets still existed in the UK but it probably never went away and is increasingly recognised as a cause of fractures in susceptible children.
Recently two parents, Rohan Wray and Chana al-Alas, were accused of murdering their four-month-old baby who died two years ago from sudden infant death syndrome (Sids, also known as cot death). The baby, Jayden, was found to have multiple injuries and the parents were accused of shaking the baby to death. But pathologist Dr Irene Scheimberg, based at Royal London Hospital, found evidence of rickets in Jayden at postmortem and the judge directed the jury to acquit.
Since that tragic case, Scheimberg says she has discovered vitamin D deficiency in eight further cases of Sids and in 30 cases of children who have died of various causes and had postmortems. A colleague of hers, Dr Marta Cohen, working in Yorkshire has also found vitamin D deficiency in 18 out of 24 cases of Sids and in 45 babies under the age of one, who died of other causes. Both doctors are calling for further investigation into the implications of vitamin D deficiency and highlighting the need to be aware of rickets in cases of Sids, which can be mistaken for non-accidental injury.
This adds weight to those calling for widespread vitamin D supplementation in the UK. Advice from the chief medical officer for England, Sally Davies, was for at-risk groups – which includes pregnant and breastfeeding women, children aged six months to five years old, people aged 65 or over, people who are not exposed to much sun (the housebound, those who cover up their skin for cultural reasons and people who have darker skin, whose bodies are unable to produce vitamin D as easily) – to take vitamin D. But there have been calls to introduce supplements for all the population in Scotland, because of high levels of multiple sclerosis which may be linked to vitamin D deficiency. Ryan McLaughlin, 13, launched a campaign, Shine on Scotland, in response to his mother’s diagnosis of MS, while Professor George Ebers of the Nuffield department of clinical neurosciences at Oxford University believes the evidence is now good enough to justify dosing the entire population with vitamin D. Professor George Ebers of the Nuffield Department of Clinical Neurosciences at Oxford University is quoted, saying that he believes the evidence is now good enough to justify dosing the entire population with vitamin D. Last month, his team published evidence of a link between MS and an inherited tendency that leads to vitamin D deficiency.
Scotland’s chief medical officer, however, Sir Harry Burns, says in the same article he thinks there needs to be “broader scientific consensus” before change is considered. He warns that dietary supplements can cause harm and that we need to wait for good randomised studies in large populations. He wants to wait for the conclusions of a review of the evidence by the UK government’s scientific advisory committee on nutrition in 2014.
But Ebers says that is too long. He reflects that there was evidence to support recommending folic acid supplementation for all pregnant women to prevent problems like spina bifida, many years before the public health authorities backed it.
Bruce Hollis, professor of paediatrics and biochemistry at the Medical University of South Carolina, agrees, insisting there’s no point waiting for a large randomised trial because it’s unlikely to ever happen. He says it would be hard to attract funding for an expensive, large scale trial as drug companies would be unlikely to make a profit on cheap vitamin supplements.
The best source of vitamin D is sunlight on the skin. Vitamin D is also found in a small number of foods (oily fish, eggs, cheese and meat) but it is difficult to get enough vitamin D from diet alone. In the UK, all margarines and infant formula milks are already fortified with vitamin D and it is also added, in small amounts, to other foods such as breakfast cereals, soya and some dairy products,. Breastfeeding mothers need adequate vitamin D levels of their own to ensure their babies get enough.
You can buy single vitamin D supplements at most pharmacies and supermarkets. Pregnant women who take vitamin D as part of a multivitamin should avoid supplements containing vitamin A (retinol), which can be harmful in pregnancy.
While the experts continue to debate, we may all be well advised to take a daily vitamin D supplement and expose our skin to whatever weak winter sunshine we can.
guardian.co.uk © Guardian News & Media Limited 2010
Published via the Guardian News Feed plugin for WordPress.